PRE-CONFERENCE WORKSHOPS (pm only) and TRAINING COURSE (full day - PT (Pacific Time, GMT-08:00)
PRE-CONFERENCE WORKSHOPS (pm only) and TRAINING COURSE (full day - PT (Pacific Time, GMT-08:00)
search
Streams
Formats
8:00am - 9:00am60 mins
Training Course Registration
OPTIONAL PRE-CONFERENCE TRAINING COURSE 9:00 am - 5:00 pm -and PRE-CONFERENCE WORKSHOPS 1:00 PM - 5:00 PM
9:00am - 5:00pm480 mins
Training Course: Introduction to Antibody Engineering
Introduction to Antibody Engineering
- David Bramhill, PhD - Consultant, Bramhill Biological Consulting, LLC
1:00pm - 1:15pm15 mins
Workshop 1: Quantitative Systems Pharmacology in Antibody Development
Co-Chairs' Remarks: Quantitative Systems Pharmacology in Antibody Development
- Karl Dane Wittrup, Ph.D. - C.P. Dubbs Professor in Chemical Engineering and Biological Engineering, Massachusetts Institute of Technology
- Stephen Beers, PhD - Professor of Immunology and Immunotherapy, University of Southampton
1:00pm - 1:15pm15 mins
Workshop 2: Innovate, Invest, Succeed: The Business Landscape of Antibody Therapeutics
Co-Chairs' Remarks: Innovate, Invest, Succeed: The Business Landscape of Antibody Therapeutics
- Jennifer Cochran, Ph.D. - Professor and Department Chair of Bioengineering, Stanford University
- Jonathan Sockolosky, PhD - Senior Director, CSO Partner Team, Curie.Bio
1:15pm - 1:45pm30 mins
Workshop 1: Quantitative Systems Pharmacology in Antibody Development
Advances in Understanding Cell Signaling in Immunotherapeutics
- Douglas Lauffenburger, PhD - Ford Professor of Bioengineering, Massachusetts Institute of Technology
1:15pm - 1:45pm30 mins
Workshop 2: Innovate, Invest, Succeed: The Business Landscape of Antibody Therapeutics
Antibody Therapeutics: Riding the Pendulum of Innovation
- Lazar Bojic, Ph.D. - Vice President of Investor Network, Curie.Bio
1:45pm - 2:15pm30 mins
Workshop 1: Quantitative Systems Pharmacology in Antibody Development
Mathematical Modeling of Response to Immunotherapy in Pancreatic Ductal Adenocarcinoma
- Daniel Bergman, Ph.D. - Postdoctoral Fellow, Johns Hopkins Medicine
1:45pm - 2:15pm30 mins
Workshop 2: Innovate, Invest, Succeed: The Business Landscape of Antibody Therapeutics
Protecting Innovations: IP Strategies for Antibody Therapeutics in a Competitive Market
- Robin Silva - Consulting Patent Attorney, Xencor
2:15pm - 2:45pm30 mins
Workshop 1: Quantitative Systems Pharmacology in Antibody Development
Designing Clinically Effective Antibody Drug Conjugates in Solid Tumors Using Quantitative Systems Pharmacology
- Greg Thurber, Ph.D. - Assistant Professor, Chemical and Biomedical Engineering, University of Michigan
2:15pm - 2:45pm30 mins
Workshop 2: Innovate, Invest, Succeed: The Business Landscape of Antibody Therapeutics
Investing in Antibody-based Therapeutics
- Sarah Hymowitz - Partner, The Column Group
2:45pm - 3:15pm30 mins
Workshop 1: Quantitative Systems Pharmacology in Antibody Development
Networking Refreshment Break
2:45pm - 3:15pm30 mins
Workshop 2: Innovate, Invest, Succeed: The Business Landscape of Antibody Therapeutics
Networking Refreshment Break
3:15pm - 3:45pm30 mins
Workshop 1: Quantitative Systems Pharmacology in Antibody Development
Bridging the In Vitro to In Vivo Gap for T-cell Engagers Using QSP Modeling
- David Flowers, Ph.D. - Director, ABS, Certara
3:15pm - 3:45pm30 mins
Workshop 2: Innovate, Invest, Succeed: The Business Landscape of Antibody Therapeutics
Tackling the Impossible Task of Project Selection in An Early Stage Biotech Startup
- Alexey Lugovskoy, Ph.D. - President and CEO, Diagonal Therapeutics
3:45pm - 4:15pm30 mins
Workshop 1: Quantitative Systems Pharmacology in Antibody Development
Modeling Immunological Synapse Formation Initiated by Bispecific T cell Engagers: What, Why and How
- Yanguang Cao, PhD - Associate Professor, University of North Carolina at Chapel Hill
3:45pm - 4:15pm30 mins
Workshop 2: Innovate, Invest, Succeed: The Business Landscape of Antibody Therapeutics
Carving out a Path to Differentiation in a Crowded Therapeutics Market
- Shelley Force Aldred, Ph.D. - CEO, Rondo Therapeutics
4:15pm - 4:45pm30 mins
Workshop 1: Quantitative Systems Pharmacology in Antibody Development
Late Breaking Presentation
4:15pm - 4:45pm30 mins
Workshop 2: Innovate, Invest, Succeed: The Business Landscape of Antibody Therapeutics
Panel Discussion
- Jonathan Sockolosky, PhD - Senior Director, CSO Partner Team, Curie.Bio
- Jennifer Cochran, Ph.D. - Professor and Department Chair of Bioengineering, Stanford University
4:45pm - 5:00pm15 mins
Workshop 1: Quantitative Systems Pharmacology in Antibody Development
Concluding Remarks
4:45pm - 5:00pm15 mins
Workshop 2: Innovate, Invest, Succeed: The Business Landscape of Antibody Therapeutics
Concluding Remarks
5:00pm - 5:05pm5 mins
Close of Workshops and Training Course
* 活動內容有可能不事先告知作更動及調整。